Fáilte chuig an Institiúid um Leigheas Athghiniúnach
Welcome to the Regenerative Medicine Institute (REMEDI®)

Stem Cell Clinical Trials to Tackle Diabetes

November 19th 2012

A major new €6 million European project designed to address complications associated with diabetes and led by REMEDI and Orbsen Therapeutics is featured in todays Irish Times.

The research project will examine the ability of stem cells to safely control glucose levels and alleviate the damage caused by six different diabetic complications.

Professor Timothy O’Brien, Director of the Regenerative Medicine Institute (REMEDI) at NUI Galway, who is also a Consultant in Endocrinology at Galway University Hospitals, will co-ordinate the project. Orbsen Therapeutics Limited, an NUI Galway spin-out company, is the lead SME on the project. Clinical trials will take place in Ireland and Denmark using stem cells discovered by Orbsen. In total, nine new research jobs are to be created in Ireland by the project.

The full story is available at: http://www.irishtimes.com/newspaper/finance/2012/1119/1224326783026.html